Nipro Corporation (TYO:8086)
1,349.00
+26.00 (1.97%)
Mar 12, 2025, 12:32 PM JST
Nipro Revenue
Nipro had revenue of 167.27B JPY in the quarter ending December 31, 2024, with 9.13% growth. This brings the company's revenue in the last twelve months to 626.93B, up 8.46% year-over-year. In the fiscal year ending March 31, 2024, Nipro had annual revenue of 586.79B with 7.63% growth.
Revenue (ttm)
626.93B
Revenue Growth
+8.46%
P/S Ratio
0.35
Revenue / Employee
16.45M
Employees
38,117
Market Cap
216.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 586.79B | 41.59B | 7.63% |
Mar 31, 2023 | 545.20B | 50.41B | 10.19% |
Mar 31, 2022 | 494.79B | 39.23B | 8.61% |
Mar 31, 2021 | 455.56B | 13.04B | 2.95% |
Mar 31, 2020 | 442.52B | 16.12B | 3.78% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |